alexa Lina Jandorf | OMICS International
ISSN: 2161-0711

Journal of Community Medicine & Health Education
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Lina Jandorf

Principal Investigator Director of Cancer Community Outreach in the Department of Oncological Sciences Tisch Cancer Institute

Biography

Lina Jandorf is the Director of Cancer Community Outreach in the Department of Oncological Sciences as well as the Director of Minority, Outreach, Recruitment and Education (MORE) for the Tisch Cancer Institute. Working with community agencies and health organizations, Ms. Jandorf is responsible for bringing cancer education and screening programs to medically underserved communities and recruiting minority residents into our research efforts. One early outcome of this work was the funding, by the National Cancer Institute, of a five year grant to develop the East Harlem Partnership for Cancer Awareness, a coalition of hospitals, community health centers, and community agencies with the common goal of increasing cancer awareness and thereby preventive care in East Harlem. In addition, Ms. Jandorf has been funded to establish the Witness Project of Harlem, a faith-based breast and cervical education program targeting African American women and Esperanza y Vida, a faith-based breast and cervical education program for Latino families. Ms. Jandorf is an active member of New York State’s Cancer Consortium Steering Committee and a member of the steering committee for New York City’s Citywide Colon Cancer Control Coalition. In collaboration with other faculty in the Department of Oncological Sciences and with Steven Itzkowitz, M.D. (Division of Gastroenterology) she has developed a patient navigation program to increase adherence to physician recommended screening colonoscopy. These National Cancer Institute funded projects have tested different forms of navigation guidance through the medical system including peer navigators (community volunteers) who themselves have completed a colonoscopy. Ms. Jandorf has also taken the lead in the Department of Oncological Sciences effort to establish Cancer Family Registries. These databases, specific to cancer site, include both index patients and family members. They allow us to establish the relative risk of various cancers and related disorders. In addition, the registries include information about medical practices, family history, nutrition, recreational activities, and exercise. Ms. Jandorf also directs a number of clinical initiatives, funded through the Division of Gastroenterology (Steven Itzkowitz, M.D.), exploring new, less invasive ways to screen for colorectal cancer. These include stool-based methodologies for both average risk individuals and those at higher risk due related to Irritable Bowel Disorders (Ulcerative Colitis and Crohn's Disease).

Research Interest

Lina Jandorf’s research efforts are focused on reducing disparities in cancer screening, early detection, and mortality. This work has been focused on understanding cultural, interpersonal and organizational barriers to cancer screening as well as important associations between health disparities and mortality and morbidity. Through the use of Peer Lay Health Workers, her research focuses on the development and implementation of culturally and linguistically appropriate interventions to support and encourage cancer screening for medically underserved individuals. Ms. Jandorf also directs a number of clinical initiatives, funded through the Division of Gastroenterology (Steven Itzkowitz, M.D.), exploring new, less invasive ways to screen for colorectal cancer. These include stool-based methodologies for both average risk individuals and those at higher risk due related to Irritable Bowel Disorders (Ulcerative Colitis and Crohn's Disease).

Publications
Relevant Topics
Top